Study of Microbicide Gel Shows Reduced Risk of HIV & Herpes Infections in Women

Author:
FHI
Publisher:
Family Health International
Publication Date:
19 July 2010
Tags:
South Africa, HIV-Aids and STDs

FHI contributed to a clinical trial in South Africa of a vaginal gel that has been shown to be 39% effective in reducing women's risk of HIV infection and 51% effective in preventing new herpes infections.

Follow AllAfrica

AllAfrica publishes around 400 reports a day from more than 100 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.